文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

嗜极50S核糖体蛋白L35Ae的衍生物作为一种替代蛋白支架

Derivative of Extremophilic 50S Ribosomal Protein L35Ae as an Alternative Protein Scaffold.

作者信息

Lomonosova Anna V, Ulitin Andrei B, Kazakov Alexei S, Mirzabekov Tajib A, Permyakov Eugene A, Permyakov Sergei E

机构信息

Institute for Biological Instrumentation of the Russian Academy of Sciences, Pushchino, Moscow region, Russia.

Antherix, Pushchino, Moscow region, Russia.

出版信息

PLoS One. 2017 Jan 19;12(1):e0170349. doi: 10.1371/journal.pone.0170349. eCollection 2017.


DOI:10.1371/journal.pone.0170349
PMID:28103321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5245882/
Abstract

Small antibody mimetics, or alternative binding proteins (ABPs), extend and complement antibody functionality with numerous applications in research, diagnostics and therapeutics. Given the superiority of ABPs, the last two decades have witnessed development of dozens of alternative protein scaffolds (APSs) for the design of ABPs. Proteins from extremophiles with their high structural stability are especially favorable for APS design. Here, a 10X mutant of the 50S ribosomal protein L35Ae from hyperthermophilic archaea Pyrococcus horikoshii has been probed as an APS. A phage display library of L35Ae 10X was generated by randomization of its three CDR-like loop regions (repertoire size of 2×108). Two L35Ae 10X variants specific to a model target, the hen egg-white lysozyme (HEL), were isolated from the resulting library using phage display. The affinity of these variants (L4 and L7) to HEL ranges from 0.10 μM to 1.6 μM, according to surface plasmon resonance data. While L4 has 1-2 orders of magnitude lower affinity to HEL homologue, bovine α-lactalbumin (BLA), L7 is equally specific to HEL and BLA. The reference L35Ae 10X is non-specific to both HEL and BLA. L4 and L7 are more resistant to denaturation by guanidine hydrochloride compared to the reference L35Ae 10X (mid-transition concentration is higher by 0.1-0.5 M). Chemical crosslinking experiments reveal an increased propensity of L4 and L7 to multimerization. Overall, the CDR-like loop regions of L35Ae 10X represent a proper interface for generation of functional ABPs. Hence, L35Ae is shown to extend the growing family of protein scaffolds dedicated to the design of novel binding proteins.

摘要

小型抗体模拟物或替代结合蛋白(ABP)扩展并补充了抗体的功能,在研究、诊断和治疗领域有众多应用。鉴于ABP的优越性,在过去二十年中见证了数十种用于设计ABP的替代蛋白质支架(APS)的开发。来自极端嗜热菌的具有高结构稳定性的蛋白质尤其有利于APS设计。在此,对来自嗜热古菌火球菌的50S核糖体蛋白L35Ae的10倍突变体进行了作为APS的探索。通过对其三个类互补决定区(CDR)样环区域进行随机化,构建了L35Ae 10X的噬菌体展示文库(库容量为2×108)。使用噬菌体展示从所得文库中分离出两种对模型靶标鸡蛋清溶菌酶(HEL)具有特异性的L35Ae 10X变体。根据表面等离子体共振数据,这些变体(L4和L7)对HEL的亲和力范围为0.10 μM至1.6 μM。虽然L4对HEL同源物牛α-乳白蛋白(BLA)的亲和力低1-2个数量级,但L7对HEL和BLA具有同等特异性。参考L35Ae 10X对HEL和BLA均无特异性。与参考L35Ae 10X相比,L4和L7对盐酸胍变性更具抗性(中间转变浓度高0.1-0.5 M)。化学交联实验表明L4和L7多聚化的倾向增加。总体而言,L35Ae 10X的类CDR环区域代表了产生功能性ABP的合适界面。因此,L35Ae被证明扩展了致力于设计新型结合蛋白的不断增长的蛋白质支架家族。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/2661fec9dc96/pone.0170349.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/2b373fde5981/pone.0170349.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/74ec17a8e62e/pone.0170349.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/b2121ba37ce5/pone.0170349.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/de1317552d96/pone.0170349.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/f07ccf8c19e2/pone.0170349.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/2661fec9dc96/pone.0170349.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/2b373fde5981/pone.0170349.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/74ec17a8e62e/pone.0170349.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/b2121ba37ce5/pone.0170349.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/de1317552d96/pone.0170349.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/f07ccf8c19e2/pone.0170349.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d87/5245882/2661fec9dc96/pone.0170349.g006.jpg

相似文献

[1]
Derivative of Extremophilic 50S Ribosomal Protein L35Ae as an Alternative Protein Scaffold.

PLoS One. 2017-1-19

[2]
Extremophilic 50S Ribosomal RNA-Binding Protein L35Ae as a Basis for Engineering of an Alternative Protein Scaffold.

PLoS One. 2015-8-6

[3]
Solution NMR structure of the ribosomal protein RP-L35Ae from Pyrococcus furiosus.

Proteins. 2012-4-16

[4]
Crystal structure of the DUF54 family protein PH1010 from hyperthermophilic archaea Pyrococcus horikoshii OT3.

Proteins. 2009-1

[5]
Affinity transfer to the archaeal extremophilic Sac7d protein by insertion of a CDR.

Protein Eng Des Sel. 2014-10

[6]
A fifth protein subunit Ph1496p elevates the optimum temperature for the ribonuclease P activity from Pyrococcus horikoshii OT3.

Biochem Biophys Res Commun. 2006-5-12

[7]
Highly stable binding proteins derived from the hyperthermophilic Sso7d scaffold.

J Mol Biol. 2011-4-16

[8]
In vitro phosphorylation of initiation factor 2 alpha (aIF2 alpha) from hyperthermophilic archaeon Pyrococcus horikoshii OT3.

J Biochem. 2004-4

[9]
Crystal structure of an RtcB homolog protein (PH1602-extein protein) from Pyrococcus horikoshii reveals a novel fold.

Proteins. 2006-6-1

[10]
Structural analysis of the transcriptional regulator homolog protein from Pyrococcus horikoshii OT3.

Proteins. 2006-6-1

本文引用的文献

[1]
Library-based display technologies: where do we stand?

Mol Biosyst. 2016-7-19

[2]
Extremophilic 50S Ribosomal RNA-Binding Protein L35Ae as a Basis for Engineering of an Alternative Protein Scaffold.

PLoS One. 2015-8-6

[3]
Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy.

Annu Rev Pharmacol Toxicol. 2015

[4]
Antibody mimetics: promising complementary agents to animal-sourced antibodies.

Crit Rev Biotechnol. 2016

[5]
Engineered proteins with desired specificity: DARPins, other alternative scaffolds and bispecific IgGs.

Curr Opin Struct Biol. 2014-8

[6]
From the discovery of monoclonal antibodies to their therapeutic application: an historical reappraisal.

Immunol Lett. 2014-9

[7]
Potent and specific inhibition of glycosidases by small artificial binding proteins (affitins).

PLoS One. 2014-5-13

[8]
Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.

FEBS Lett. 2013-11-12

[9]
The emerging role of new protein scaffold-based agents for treatment of cancer.

Cancer Genomics Proteomics. 2013

[10]
Analysis Tool Web Services from the EMBL-EBI.

Nucleic Acids Res. 2013-5-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索